Cetera Investment Advisers
ESPR

Cetera Investment Advisers’s Esperion Therapeutics ESPR Stock Holding History

Cetera Investment Advisers’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.8K Sell
31,681
-122
-0.4% -$386 ﹤0.01% 4491
2025
Q4 		$118K Sell
31,803
-29,003
-48% -$93.7K ﹤0.01% 4360
2025
Q3 		$161K Buy
60,806
+41,769
+219% +$80.8K ﹤0.01% 4212
2025
Q2 		$18.7K Sell
19,037
-2,727
-13% -$2.73K ﹤0.01% 4030
2025
Q1 		$31.3K Buy
21,764
+989
+5% +$1.82K ﹤0.01% 3894
2024
Q4 		$45.7K Buy
20,775
+5,150
+33% +$12K ﹤0.01% 3662
2024
Q3 		$25.8K Buy
15,625
+96
+0.6% +$194 ﹤0.01% 3640
2024
Q2 		$34.5K Buy
15,529
+9
+0.1% +$21 ﹤0.01% 3620
2024
Q1 		$41.6K Buy
+15,520
New +$37.7K ﹤0.01% 3583

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return